INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 64 filers reported holding INFINITY PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $5,000 | -28.6% | 1,507 | -32.6% | 0.00% | – |
| Q1 2021 | $7,000 | +250.0% | 2,237 | +183.9% | 0.00% | – |
| Q4 2020 | $2,000 | +100.0% | 788 | +6.8% | 0.00% | – |
| Q3 2019 | $1,000 | -75.0% | 738 | -68.0% | 0.00% | – |
| Q2 2019 | $4,000 | 0.0% | 2,308 | 0.0% | 0.00% | – |
| Q1 2019 | $4,000 | +33.3% | 2,308 | 0.0% | 0.00% | – |
| Q4 2018 | $3,000 | -50.0% | 2,308 | 0.0% | 0.00% | – |
| Q3 2018 | $6,000 | +50.0% | 2,308 | 0.0% | 0.00% | – |
| Q2 2018 | $4,000 | -20.0% | 2,308 | +5.3% | 0.00% | – |
| Q1 2018 | $5,000 | +25.0% | 2,191 | 0.0% | 0.00% | – |
| Q4 2017 | $4,000 | -20.0% | 2,191 | -43.5% | 0.00% | – |
| Q3 2017 | $5,000 | -16.7% | 3,876 | 0.0% | 0.00% | – |
| Q2 2017 | $6,000 | -53.8% | 3,876 | 0.0% | 0.00% | – |
| Q1 2017 | $13,000 | +160.0% | 3,876 | 0.0% | 0.00% | – |
| Q4 2016 | $5,000 | -16.7% | 3,876 | +6.5% | 0.00% | – |
| Q3 2016 | $6,000 | +500.0% | 3,641 | +317.1% | 0.00% | – |
| Q2 2016 | $1,000 | – | 873 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 17,426,968 | $36,945,000 | 1.45% |
| Opaleye Management Inc. | 3,171,800 | $6,724,000 | 0.88% |
| EAM Investors, LLC | 421,103 | $893,000 | 0.15% |
| Bleichroeder LP | 250,000 | $530,000 | 0.10% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 755,593 | $1,602,000 | 0.04% |
| Callan Capital, LLC | 73,200 | $155,000 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 419,300 | $889,000 | 0.02% |
| Private Wealth Advisors, Inc. | 12,000 | $25,000 | 0.01% |
| Alpine Global Management, LLC | 24,575 | $52,000 | 0.01% |
| Evercore Wealth Management, LLC | 143,138 | $303,000 | 0.01% |